Omnicell Long Term Debt 2010-2024 | OMCL
Omnicell Annual Long Term Debt (Millions of US $) |
|
---|---|
2023 | $570 |
2022 | $567 |
2021 | $ |
2020 | $467 |
2019 | $50 |
2018 | $135 |
2017 | $195 |
2016 | $246 |
2015 | $ |
2014 | $ |
2013 | $ |
2012 | $ |
2011 | $ |
2010 | $ |
2009 | $ |
Omnicell Quarterly Long Term Debt (Millions of US $) |
|
---|---|
2024-03-31 | $570 |
2023-12-31 | $570 |
2023-09-30 | $569 |
2023-06-30 | $568 |
2023-03-31 | $567 |
2022-12-31 | $567 |
2022-09-30 | $566 |
2022-06-30 | $565 |
2022-03-31 | |
2021-12-31 | |
2021-09-30 | $483 |
2021-06-30 | $478 |
2021-03-31 | $472 |
2020-12-31 | $467 |
2020-09-30 | $462 |
2020-06-30 | |
2020-03-31 | |
2019-12-31 | $50 |
2019-09-30 | $77 |
2019-06-30 | $77 |
2019-03-31 | $97 |
2018-12-31 | $135 |
2018-09-30 | $167 |
2018-06-30 | $181 |
2018-03-31 | $190 |
2017-12-31 | $195 |
2017-09-30 | $179 |
2017-06-30 | $184 |
2017-03-31 | $206 |
2016-12-31 | $246 |
2016-09-30 | $215 |
2016-06-30 | $217 |
2016-03-31 | $219 |
2015-12-31 | |
2015-09-30 | |
2015-06-30 | |
2015-03-31 | |
2014-12-31 | |
2014-09-30 | |
2014-06-30 | |
2014-03-31 | |
2013-12-31 | |
2013-09-30 | |
2013-06-30 | |
2013-03-31 | |
2012-12-31 | |
2012-09-30 | |
2012-06-30 | |
2012-03-31 | |
2011-12-31 | |
2011-09-30 | |
2011-06-30 | |
2011-03-31 | |
2010-12-31 | |
2010-09-30 | |
2010-06-30 | |
2010-03-31 | |
2009-12-31 | |
2009-09-30 | |
2009-06-30 | |
2009-03-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $1.229B | $1.147B |
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $35.257B | 19.36 |
Tempus AI (TEM) | United States | $5.669B | 0.00 |
Hims & Hers Health (HIMS) | United States | $4.401B | 0.00 |
Inspire Medical Systems (INSP) | United States | $3.980B | 0.00 |
Axonics (AXNX) | United States | $3.445B | 0.00 |
Olink Holding AB (publ) (OLK) | Sweden | $3.202B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.010B | 0.00 |
Azenta (AZTA) | United States | $2.800B | 157.42 |
Enovis (ENOV) | United States | $2.438B | 18.07 |
10x Genomics (TXG) | United States | $2.234B | 0.00 |
Privia Health (PRVA) | United States | $2.022B | 113.00 |
Schrodinger (SDGR) | United States | $1.461B | 0.00 |
Phreesia (PHR) | United States | $1.177B | 0.00 |
Standard BioTools (LAB) | United States | $0.682B | 0.00 |
Definitive Healthcare (DH) | United States | $0.631B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.621B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.596B | 0.00 |
Health Catalyst (HCAT) | United States | $0.365B | 0.00 |
Talkspace (TALK) | United States | $0.365B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.305B | 0.00 |
Pulmonx (LUNG) | United States | $0.245B | 0.00 |
Butterfly Network (BFLY) | United States | $0.209B | 0.00 |
Outset Medical (OM) | United States | $0.199B | 0.00 |
TruBridge (TBRG) | United States | $0.168B | 9.02 |
P3 Health Partners (PIII) | United States | $0.157B | 0.00 |
American Well (AMWL) | United States | $0.089B | 0.00 |
111 (YI) | China | $0.088B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.080B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
HeartBeam (BEAT) | United States | $0.071B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
MSP Recovery (LIFW) | United States | $0.057B | 0.00 |
Augmedix (AUGX) | United States | $0.049B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.048B | 0.00 |
Zepp Health (ZEPP) | China | $0.039B | 0.00 |
CareCloud (CCLD) | United States | $0.032B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.031B | 0.00 |
Movano (MOVE) | United States | $0.031B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Syra Health (SYRA) | United States | $0.008B | 0.00 |
Biotricity (BTCY) | United States | $0.007B | 0.00 |
Transgenomic (PRPO) | United States | $0.007B | 0.00 |
Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.003B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |